ASBURY AUTOMOTIVE GROUP INC

Company Overview

Asbury Automotive Group is a Fortune 500 franchised automotive retailer operating ~152 dealership locations (198 new-vehicle franchises) and 37 collision centers across 14 U.S. states, reporting through two segments: Dealerships and Total Care Auto (TCA), its captive F&I provider. Revenue is diversified across new- and used-vehicle sales, parts & service (a growing and stable profit stream), collision, and F&I premiums/commissions; 2024 consolidated revenue was $17.19 billion with gross profit of $2.95 billion and a 17.2% consolidated gross margin. Growth is driven by same-store improvements, digital omni-channel initiatives and selective acquisitions (Koons in 2023 and the Herb Chambers transaction announced in 2025), while material risks include manufacturer franchise agreements, interest/floor-plan costs, potential impairments, and regulatory oversight by the FTC/CFPB and state insurance regulators.

Executive Compensation Practices

Compensation is likely structured around a mix of base salary, annual cash incentives and long‑term equity (RSUs/PSUs and possible option grants), with performance metrics tied to dealer-specific and corporate KPIs such as same-store gross profit, unit volumes, parts & service and F&I profitability, adjusted operating income, and return on invested capital. Recent disclosures (new-vehicle gross profit per unit down ~21% and used down ~22%, SG&A +17%, floor‑plan interest up materially to ~$89.9M) suggest incentive plans will rely on adjusted, transaction‑neutral metrics (e.g., adjusted operating cash flow, transaction‑adjusted leverage) to normalize acquisition effects and transient margin volatility. Given Asbury’s acquisition-driven growth strategy and large integration items (Koons and Herb Chambers), executives will commonly have deal-related milestones, retention awards and multi-year performance conditions tied to successful integration, leverage targets and impairment avoidance; clawback and governance provisions are also likely given impairment sensitivity and regulatory oversight of F&I.

Insider Trading Considerations

Insider activity at Asbury is likely influenced by acquisition events, quarterly earnings and manufacturer/stop‑sale announcements that materially affect unit supply and per‑unit margins; large M&A financings (Herb Chambers) and changes in leverage or covenant headroom are material catalysts for insider buys/sells. Equity vesting schedules and option exercises tied to long‑term incentives create predictable Form 4 activity, while executives may use Rule 10b5‑1 plans to mitigate appearance of trading on nonpublic integration or impairment information—watch for filings around acquisition close dates and DMS/TCA integration milestones. Regulatory constraints (FTC/CFPB scrutiny of F&I, state insurance rules for TCA) and internal blackout policies around material events make it important to monitor the timing of trades, Form 4 disclosure patterns, and any unusual insider selling that coincides with deteriorating margins, impairment charges or covenant pressure.